Breaking News Instant updates and real-time market news.

CHL

China Mobile

$45.51

-0.3 (-0.65%)

19:04
03/22/18
03/22
19:04
03/22/18
19:04

China Mobile upgraded to Hold from Underperform at Jefferies

CHL China Mobile
$45.51

-0.3 (-0.65%)

08/30/17
BOFA
08/30/17
INITIATION
BOFA
Buy
China Mobile reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Danny Chu reinstated China Mobile with a Buy citing rising free-cash-flow from stable operating cash flow and slowing capex, and 4G business dominance.
12/20/17
RILY
12/20/17
NO CHANGE
Target $89
RILY
Buy
Lumentum to supply China Telecom's ROADM deployment, says B. Riley FBR
B. Riley FBR analyst Dave Kang says multiple Chinese media sources indicate that China Telecom (CHA) plans to deploy a ROADM-based network in both Northern and Southern China after successfully deploying a similar network in the middle and lower sections of the Yangtze River region. The analyst believes Lumentum (LITE) will be the primary supplier of ROADMs, or reconfigurable optical add/drop multiplexers. He points out the company's management recently indicated that several products, including ROADMs, have been expedited by Chinese customers. Further, Kang expects China Mobile (CHL) to follow China Telecom's lead, most likely in mid-2018. The analyst thinks the Chinese ROADM cycle will be an important catalyst for Lumentum in 2018 and beyond. The stock is up 11c to $53.51 in afternoon trading. Kang has a Buy rating on Lumentum with an $89 price target.
03/05/18
HSBC
03/05/18
UPGRADE
HSBC
Buy
China Mobile upgraded to Buy from Hold at HSBC
03/12/18
NOMU
03/12/18
DOWNGRADE
NOMU
Neutral
China Mobile downgraded to Neutral from Buy at Nomura Instinet
Nomura analyst Joel Ying downgraded China Mobile to Neutral.

TODAY'S FREE FLY STORIES

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Wynn Resorts sees opening Boston Harbor project in mid-2019 »

With its earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Dare Bioscience, Juniper emter into exclusive worldwide license agreement »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Wynn Resorts CEO says Boston project not for sale »

Wynn Resorts CEO Matt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Twitter CEO says soliciting external experts to improve health of service »

CEO Jack Dorsey said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

AVXS

AveXis

$210.76

0.77 (0.37%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
AveXis announces first patient dosed in Phase 3 trial of AVXS-101 »

AveXis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

PHM

PulteGroup

$29.66

0.84 (2.91%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Earnings
Hess Midstream Partners reaffirms FY18 net income view $335M-$360M »

Reaffirms FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CUE

Cue Biopharma

$13.45

-0.03 (-0.22%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
Cue Biopharma appoints Anish Suri, Ph.D. as Chief Scientific Officer »

Cue Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.16

-14.855 (-6.88%)

08:10
04/25/18
04/25
08:10
04/25/18
08:10
Recommendations
3M analyst commentary  »

3M price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 18

    May

  • 30

    May

CEMI

Chembio Diagnostics

$7.80

-0.05 (-0.64%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Hot Stocks
Chembio Diagnostics, LumiraDx enter collaboration for POC diagnostic tests »

Chembio Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 29

    May

EW

Edwards Lifesciences

$134.63

-2.59 (-1.89%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Downgrade
Edwards Lifesciences rating change  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

INSE

Inspired Entertainment

$4.85

-0.4 (-7.62%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Inspired Entertainment signs games content agreement with Novomatic »

Inspired Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$42.96

-2.44 (-5.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Recommendations
Mercury Systems analyst commentary  »

Mercury Systems weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Hess Midstream Partners reports Q1 EPS 30c, consensus 28c »

Reports Q1 revenue $157M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Twitter: 'Privacy is a fundamental right for everyone we serve on our service' »

Comment taken from the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Amphenol increases dividend 21% to 23c per share, approves $2B buyback plan »

Amphenol's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

LKFN

Lakeland Financial

$48.90

0.46 (0.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Lakeland Financial reports Q1 EPS 71c, consensus 70c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$64.14

-0.25 (-0.39%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Periodicals
Icahn says Washington not for him, hasn't spoken with Trump in months »

"Neither I nor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$38.62

0.18 (0.47%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Hot Stocks
Hologic: FDA grants premarket approval for ThinPrep Integrated Imager »

Hologic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 08

    May

  • 12

    Jun

CPF

Central Pacific

$31.00

0.63 (2.07%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Earnings
Central Pacific reports Q1 EPS 48c, consensus 31c »

Reports Q1 NII $42.32M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:06
04/25/18
04/25
08:06
04/25/18
08:06
Earnings
Amphenol raises FY18 adjusted EPS view to $3.49-$3.55 from $3.39-$3.47 »

FY18 EPS consensus $3.46.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

, DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Hot Stocks
Juniper Pharmaceuticals licenses intravaginal ring platform to Dare Bioscience »

Juniper Pharmaceuticals…

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$162.87

-2.38 (-1.44%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Conference/Events
President Trump to meet with Apple CEO Cook »

The meeting between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

TZOO

Travelzoo

$7.75

0.2 (2.65%)

08:04
04/25/18
04/25
08:04
04/25/18
08:04
Earnings
Travelzoo reports Q1 EPS 20c, two estimates 8c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:04
04/25/18
04/25
08:04
04/25/18
08:04
Earnings
Amphenol sees Q2 adjusted EPS of 83c-85c, consensus 85c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.